V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160001576 | 160008770 | 1.78 | 70 | 03 | 2017-02-18 | 2017-03-06 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101069483 |
| 160001840 | 160008772 | 1.56 | 51 | Curative (C) | 2019-04-20 | 2019-04-28 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100537037 |
| 160001867 | 160008773 | 1.82 | 69 | Neo-adjuvant (N) | 2018-07-02 | 2018-07-02 | Temozolomide 200mg/m2 | 02 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100608098 |
| 160001933 | 160008774 | 1.52 | 55.2 | Neo-adjuvant (N) | 2017-03-29 | 2017-04-12 | Bevacizumab+Carbo+Pacliaxel | 02 | N | DOCETAXEL + GEMCITABINE | 100731289 |
| 160002009 | 160008775 | 1.76 | 103.2 | null | 2019-12-22 | 2019-12-29 | CARBOPLATIN + PACLITAXEL | 02 | N | NOT MATCHED | 100169851 |
| 160002172 | 160008776 | 1.68 | 84.4 | Palliative (P) | 2017-08-19 | 2017-08-20 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100194036 |
| 160002514 | 160008777 | 1.68 | 75.4 | Palliative (P) | 2017-03-24 | 2017-03-28 | Carboplatin + Paclitaxel (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101490250 |
| 160002544 | 160008778 | 1.58 | 43.7 | Neo-adjuvant (N) | 2018-04-16 | 2018-05-12 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100312942 |
| 160002635 | 160008779 | 1.5 | 111.8 | Palliative (P) | 2019-06-03 | 2019-06-22 | CARBOPLATIN + PACLITAXEL | 02 | N | TRIAL | 101601717 |
| 160002663 | 160008780 | 1.75 | 62.8 | Curative (C) | 2019-07-24 | 2019-08-08 | null | 02 | N | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 100494391 |
| 160002720 | 160008781 | 1.6 | 107.1 | Palliative (P) | 2018-02-08 | 2018-02-08 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101619874 |
| 160003195 | 160008782 | 1.6 | 76 | null | 2018-12-18 | 2018-12-22 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100686179 |
| 160003333 | 160008783 | 1.72 | 87.6 | Neo-adjuvant (N) | 2019-11-04 | 2019-11-08 | Doxorubicin 75mg/m2 | 02 | N | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 101395089 |
| 160003623 | 160008785 | 1.8 | 56.3 | null | null | 2018-12-17 | null | 02 | N | DOXORUBICIN + OLARATUMAB | 100312421 |
| 160003704 | 160008786 | 1.67 | 67.3 | Curative (C) | 2016-08-05 | 2016-08-19 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101329324 |
| 160003966 | 160008788 | 1.81 | 96 | Palliative (P) | 2018-01-22 | 2018-01-24 | IPM | 02 | N | TRIAL UNSPECIFIED | 100428369 |
| 160004368 | 160008790 | null | 79.1 | Neo-adjuvant (N) | 2019-05-12 | 2019-05-30 | Carboplatin AUC 2 - 5 | N | null | CARBOPLATIN | 100394972 |
| 160004387 | 160008791 | 1.65 | 71 | Curative (C) | 2018-02-13 | 2018-02-13 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | Y | N | PACLITAXEL | 101203891 |
| 160004664 | 160008792 | 1.57 | 68.1 | Curative (C) | 2016-10-17 | 2016-10-27 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101509113 |
| 160004681 | 160008793 | 1.66 | 78.1 | Palliative (P) | 2018-07-24 | 2018-08-04 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 100946623 |
| 160004977 | 160008794 | 1.81 | 55 | Palliative (P) | 2018-07-03 | 2018-07-30 | Carboplatin AUC 6 - 10 | N | N | DOXORUBICIN + IFOSFAMIDE | 100163093 |
| 160005199 | 160008795 | 1.81 | 86.4 | Palliative (P) | 2019-08-06 | 2019-08-11 | Trial Unspecified | 02 | null | IFOSFAMIDE | 100797738 |
| 160005508 | 160008796 | null | null | Curative (C) | 2017-09-14 | 2017-09-17 | Liposomal Doxorubicin (Caelyx) | 02 | N | NOT MATCHED | 100228094 |
| 160005569 | 160008797 | 1.67 | 66 | Neo-adjuvant (N) | null | 2017-09-05 | Carboplatin AUC 6 - 10 | null | N | CARBOPLATIN | 100624484 |
| 160005762 | 160008798 | 1.79 | 86.9 | null | 2016-02-05 | 2016-02-15 | IVADo | 02 | N | CYCLOPHOSPHAMIDE | 101258435 |
| 160005787 | 160008799 | 1.64 | 63.5 | Neo-adjuvant (N) | 2019-03-21 | 2019-04-04 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101316980 |
| 160005796 | 160008800 | 1.66 | 65.1 | null | 2016-05-06 | 2016-05-07 | Vinorelbine (oral) | null | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100762970 |
| 160005816 | 160008801 | 1.63 | 56.4 | Palliative (P) | 2019-03-06 | 2019-03-17 | Trial Unspecified | N | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 101864654 |
| 160006389 | 160008803 | 1.85 | 70 | Palliative (P) | 2020-02-23 | 2020-02-23 | Cisplatin + Doxorubicin | 02 | N | DOXORUBICIN + OLARATUMAB | 100953709 |
| 160006523 | 160008804 | 1.69 | 57 | Palliative (P) | 2018-10-26 | 2018-11-21 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100074533 |
| 160006528 | 160008805 | 1.65 | 133.4 | Palliative (P) | 2021-08-19 | 2021-08-19 | IVADo | 02 | N | TRIAL UNSPECIFIED | 100065336 |
| 160006529 | 160008806 | 1.68 | 84 | Palliative (P) | 2020-05-09 | 2020-07-29 | OSIMERTINIB | 02 | N | IVADO | 101225141 |
| 160006838 | 160008808 | 1.73 | 63.4 | Neo-adjuvant (N) | 2019-04-01 | 2019-04-06 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | RMS 2005 TRIAL | 100170724 |
| 160006918 | 160008809 | 1.61 | 102 | null | 2019-11-29 | 2019-11-30 | Carboplatin AUC 2 - 5 | 01 | N | CARBOPLATIN | 100003836 |
| 160007240 | 160008810 | 1.76 | 81 | Neo-adjuvant (N) | 2017-03-19 | 2017-03-19 | CARBOPLATIN + PACLITAXEL | 02 | N | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101524382 |
| 160007389 | 160008811 | 1.66 | 77 | Palliative (P) | 2016-11-15 | 2016-12-04 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100844374 |
| 160007840 | 160008812 | 1.53 | 77.3 | Curative (C) | 2018-04-02 | 2018-04-19 | Doxorubicin 75mg/m2 | N | N | CISPLATIN + PEMETREXED | 101131114 |
| 160007874 | 160008813 | 1.55 | 66.05 | Curative (C) | 2018-07-12 | 2018-07-13 | Bevacizumab | N | N | ENZALUTAMIDE | 100308455 |
| 160007904 | 160008814 | 1.59 | 90 | 03 | 2018-07-23 | 2018-07-23 | CARBOPLATIN | N | N | OLARATUMAB | 100242429 |
| 160008367 | 160008815 | 1.57 | 70 | null | 2017-10-03 | 2017-10-04 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101230002 |
| 160008397 | 160008816 | 1.61 | 78.6 | Palliative (P) | 2019-01-26 | 2019-02-09 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100505172 |
| 160008409 | 160008817 | 1.55 | 76.2 | Palliative (P) | 2020-01-08 | 2020-01-25 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | PACLITAXEL | 100647062 |
| 160008433 | 160008818 | 1.7 | 64.5 | Curative (C) | 2019-02-19 | 2019-02-20 | Pemetrexed | N | N | LIPOSOMAL DAUNORUBICIN | 100659790 |
| 160008538 | 160008819 | 1.55 | 71 | Adjuvant (A) | 2018-02-05 | 2018-02-14 | Dactinomycin + Vincristine | N | N | CISPLATIN + PEMETREXED | 101033163 |
| 160008630 | 160008820 | 1.53 | 86 | Neo-adjuvant (N) | 2018-08-30 | 2018-09-13 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100288187 |
| 160008702 | 160008821 | 1.73 | 76.6 | Adjuvant (A) | 2019-10-19 | 2019-11-09 | Trial Unspecified | Y | N | TRIAL UNSPECIFIED | 100149996 |
| 160008800 | 160008822 | 1.68 | 68.7 | Palliative (P) | 2017-07-09 | 2017-07-16 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100275941 |
| 160008830 | 160008823 | 1.81 | 93 | Palliative (P) | 2019-12-11 | 2019-12-14 | DOXORUBICIN | 01 | null | DOXORUBICIN | 100249825 |
| 160008933 | 160008824 | 1.63 | 73 | Curative (C) | 2017-03-07 | 2017-03-15 | Doxorubicin + Ifosfamide | 02 | N | CARBOPLATIN + TOPOTECAN | 101078869 |
| 160008964 | 160008825 | 1.6 | 75.8 | Palliative (P) | 2018-08-09 | 2018-08-14 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 101078776 |